Sleep News and Research

Latest Sleep News and Research

Worse sleep quality predicts lower physical activity in people with PTSD

A new study shows that worse sleep quality predicts lower physical activity in people with post-traumatic stress disorder (PTSD).

17 Jul 2014

Freedom portable driver receives FDA approval for use with SynCardia Total Artificial Heart

The Freedom portable driver received FDA approval on June 26, 2014 for use with the SynCardia temporary Total Artificial Heart as a bridge to transplantation in cardiac transplant candidates who are clinically stable.

16 Jul 2014

Verus Healthcare completes 85th acquisition of CPAP business

Verus Healthcare, Inc. recently completed its 85th acquisition of CPAP business within the durable medical equipment (DME) industry.

16 Jul 2014

CHEST to host SimGHOSTS for 4th annual meeting

The American College of Chest Physicians (CHEST) announced today the organization will host SimGHOSTS, The Gathering Of Healthcare Simulation Technology Specialists, for the organization's 4th annual meeting, in its new Innovation, Simulation, and Training Center in Glenview, Illinois, from August 5-8.

16 Jul 2014

CHEST guideline released for PAH

An updated CHEST guideline for treating pulmonary arterial hypertension provides some evidence-based recommendations but also highlights many evidence gaps.

15 Jul 2014

Nocturia affects one in three premenopausal women

Nocturia affects around one-third of women of reproductive age, a survey has found, highlighting that the condition is not confined to elderly individuals.

15 Jul 2014

Night-time BP variability improves vascular risk prediction

Measuring night-time variability in the blood pressure of patients with hypertension may help to predict their risk of having a cardiovascular event, show data from an international study.

15 Jul 2014

Acupuncture can affect severity of hot flashes for women in natural menopause

In the 2,500+ years that have passed since acupuncture was first used by the ancient Chinese, it has been used to treat a number of physical, mental and emotional conditions including nausea and vomiting, stroke rehabilitation, headaches, menstrual cramps, asthma, carpal tunnel, fibromyalgia and osteoarthritis, to name just a few.

15 Jul 2014

New data on possible protective behaviors and dementia risk factors emerges at AAIC- 2014

Participation in activities that promote mental activity, and moderate physical activity in middle age, may help protect against the development of Alzheimer's disease and dementia in later life, according to new research reported today at the Alzheimer's Association International Conference- 2014 (AAIC- 2014) in Copenhagen.

15 Jul 2014

Doctor creates TULA skincare line using Probiotic Technology

TULA (tulaforlife.com), the new skin care line using a patented Probiotic Technology, today announced the launch of their first selection of skin care products.

11 Jul 2014

Sleep problems in PD patients can worsen in later stages of disease

Up to 70% of Parkinson's disease (PD) patients experience sleep problems that negatively impact their quality of life.

11 Jul 2014

Kaleo announces U.S. availability of EVZIO for emergency treatment of opioid overdose

Kaleo, a privately-held pharmaceutical company headquartered in Richmond, Virginia, today announced the United States (U.S.) commercial availability of EVZIO for the emergency treatment of known or suspected opioid overdose, as manifested by respiratory and/or central nervous system depression.

10 Jul 2014

Experts release position statement on electronic cigarettes

Experts from the world's leading lung organizations have released a position statement on electronic cigarettes, focusing on their potential adverse effects on human health and calling on governments to ban or restrict their use until their health impacts are better known.

10 Jul 2014

NIH funds Phase II 90-subject pediatric clinical trial at UCLA

NeuroSigma, Inc., a California-based life sciences company focused on commercialization of its non-invasive Monarch eTNS System for the treatment of neurological and neuropsychiatric disorders, today announced that the U.S. National Institutes of Health (NIH) has awarded UCLA a grant that funds a Phase II 90-subject pediatric clinical trial at the University of California, Los Angeles focused on the treatment of Attention Deficit Hyperactivity Disorder (ADHD) with NeuroSigma's external trigeminal nerve stimulation (eTNS) System.

10 Jul 2014

Baptist Health, AFC partner to improve patient outcomes throughout Central Alabama

Today, Baptist Health and American Family Care announced that they have partnered to provide primary and urgent care services throughout Central Alabama.

9 Jul 2014

Acetone in breath is suitable marker of fat-burning during physical activity

Physicists at Radboud University Nijmegen have shown for the first time that the concentration of acetone in breath is a suitable marker of fat-burning during physical activity.

9 Jul 2014

Interrupted sleep patterns linked to compromised cognitive abilities

The familiar cry in the night, followed by a blind shuffle to the crib, a feeding, a diaper change, and a final retreat back into oblivion - every hour on the hour.

9 Jul 2014

Health issues become the largest contributor of stress for Americans, poll finds

A new NPR/Robert Wood Johnson Foundation/Harvard School of Public Health poll released today that examines the role of stress in Americans' lives finds that about half of the public (49%) reported that they had a major stressful event or experience in the past year. Nearly half (43%) reported that the most stressful experiences related to health.

9 Jul 2014

Researchers examine link between full moon and sleep

A Swiss research study conducted last year showed that the full moon affects sleep. The findings demonstrated that people average 20 minutes less sleep, take five minutes longer to fall asleep and experience 30 minutes more of REM sleep, during which most dreaming is believed to occur.

8 Jul 2014

Combining NRT with varenicline improves smoking abstinence

Combining the smoking cessation medication varenicline with nicotine replacement therapy was more effective than varenicline alone at achieving tobacco abstinence at 6 months, according to a study in the July 9 issue of JAMA.

8 Jul 2014